David Soskin received his BA and MD from Harvard University and completed residency at Massachusetts General Hospital (MGH) and McLean Hospital Psychiatric Residency Program before joining the MGH Department of Psychiatry. He served on faculty at Harvard Medical School and as a Principle Investigator at MGH's Depression and Clinical Research Program. His research focused on the relationship between depression and inflammation; the use of pro-dopaminergic agents to enhance behavioral activation therapy for treatment-resistant depression; the effects of antidepressants on emotional temperament; and the evaluation of other novel agents, such as low dose naltrexone, to treat unipolar depression. From 2014 to 2017, he was the Medical Director for the Behavioral Health Department of Monterey County and the Chief of Psychiatry for Natividad Medical Center.
Prior to attending Harvard Medical School, Dr. Soskin received specialty training in substance use disorders through the Zinberg Training Fellowship Program at Harvard Medical School and developed a program using literature to help individuals with substance use disorders. He was the recipient of the Joyce and Richard Tedlow Award at Harvard Medical School/Massachusetts General Hospital for excellence in integrating psychotherapy, psychopharmacology, and clinical research; the Kaplen & Livingston Fellowships for Clinical Psychopharmacology Research at Harvard Medical School/Massachusetts General Hospital; and the UCSF Residency Teaching Award at the University of California, San Francisco.
Dr. Soskin developed Open Source Psychiatry as a resource for patients, clinicians, and researchers. He created Slack Psychopharmacology as a safe and collaborative e-space for learning psychopharmacology in real-time. His books - "Open Source Psychiatry" and "13" - are available on Amazon. He also publishes on Twitter, Instagram, and YouTube.